Anavex Life Sciences Corp (AVXL)

[falconer66a]

A private bidding war, perhaps?

I repeat, possibly great Alzheimer’s TLD IS reading out this year! Like Dr. M mentioned too even if blarcasamine just stabilizes the disease it will be a huge success!

Treden, our thanks to YOU. Cogently stated points; all true. The Anavex "game" is changing, now that it's about to really start, with ensuing sales and therapeutic use approvals and consequent revenue streams.

Yes, if blarcamesine is able only to stabilize, prevent the further progression of Alzheimer's symptoms, it will produce billions of dollars of corporate revenues for Anavex, and save billions of dollars of healthcare costs to individuals, insurers, and government entities. Good enough; far better than the Alzheimer's SOC (standard of care treatment), Aricept. It merely slows Alzheimer's progression, after which, often in just a few months, the disease resumes its lethal progression.

But all of the existing data strongly suggest that blarcamesine will, indeed, reverse the symptomatic progression. Alzheimer's patients (when treated early enough) will actually improve, not just slide along at a disease-diminished baseline.

And yes, almost surely Missling has in hand TLD, top line data, from the big Alzheimer's study with blarcamesine. Those will be released to the public when most appropriate. But in the meantime, Missling can hint to other Big Pharmaceutical execs a bit about what he knows; all of which would prompt ever larger collaboration offers. If Missling decides to market blarcamesine through contract subsidiaries (other Big Pharmas), they are going to have to bid big against each other to play on the blarcamesine ballfield.